WallStreetZenWallStreetZen

NASDAQ: KROS
Keros Therapeutics Inc Stock Ownership - Who owns Keros Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Keros Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adar1 Capital Management LLC10% Owner2025-04-0918,560$9.40
$174.37kBuy
Adar1 Capital Management LLC10% Owner2025-04-0916,365$9.40
$153.75kBuy
Adar1 Capital Management LLC10% Owner2025-04-09325,000$9.86
$3.20MBuy
Adar1 Capital Management LLC10% Owner2025-04-09500,000$10.33
$5.17MBuy
Adar1 Capital Management LLC10% Owner2025-04-0974,333$10.33
$767.86kBuy
Jasbir SeehraCHIEF EXECUTIVE OFFICER2025-04-0449,367$0.30
$14.81kBuy
Carl L. GordonDirector2024-08-13220,600$44.01
$9.71MSell
Orbimed Advisors LLCDirector2024-08-1329,400$44.01
$1.29MSell
Orbimed Advisors LLCDirector2024-08-13220,600$44.01
$9.71MSell
Carl L. GordonDirector2024-08-1329,400$44.01
$1.29MSell

1 of 1

KROS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KROS insiders and whales buy or sell their stock.

KROS Shareholders

What type of owners hold Keros Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adar1 Capital Management LLC10.97%4,456,706$60.43MInsider
Nuveen LLC9.72%3,947,455$53.53MInstitution
Blackrock Inc6.86%2,785,237$37.77MInstitution
Jpmorgan Chase Co6.40%2,600,457$35.26MInstitution
Vanguard Group Inc6.32%2,566,321$34.80MInstitution
Alon Lazarus5.01%2,036,140$27.61MInsider
Arkin Bio Ventures Limited Partnership4.96%2,013,102$27.30MInsider
Logos Global Management LP4.92%2,000,000$27.12MInstitution
Morgan Stanley4.18%1,697,557$23.02MInstitution
Nantahala Capital Management LLC3.71%1,506,790$20.43MInstitution

1 of 3

KROS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KROS73.36%26.64%Net BuyingNet Buying
RLAY77.14%22.86%Net SellingNet Selling
VERV63.99%36.01%Net BuyingNet Selling
TYRA60.74%39.26%Net BuyingNet Buying
URGN80.59%19.41%Net SellingNet Selling
View Top Biotech Stocks

Keros Therapeutics Stock Ownership FAQ

Who owns Keros Therapeutics?

Keros Therapeutics (NASDAQ: KROS) is owned by 90.46% institutional shareholders, 32.85% Keros Therapeutics insiders, and 0.00% retail investors. Adar1 Capital Management LLC is the largest individual Keros Therapeutics shareholder, owning 4.46M shares representing 10.97% of the company. Adar1 Capital Management LLC's Keros Therapeutics shares are currently valued at $60.43M.

If you're new to stock investing, here's how to buy Keros Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.